Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 23, 2013
Clovis Oncology Announces CO-1686 Clinical Data Accepted as Oral Presentation at 2014 European Lung Cancer Conference Download PDF format download (opens in new window)
December 3, 2013
Clovis Oncology Announces Sale of Shares of Common Stock by Selling Stockholders Download PDF format download (opens in new window)
December 2, 2013
Clovis Oncology Announces Proposed Secondary Offering of Shares of Common Stock by Selling Stockholders Download PDF format download (opens in new window)
November 19, 2013
Clovis Oncology Acquires EOS (Ethical Oncology Science) S.p.A. to Gain Rights to Lucitanib, a Unique Dual-Selective Phase II FGFR/VEGFR Inhibitor Download PDF format download (opens in new window)
November 5, 2013
Clovis Oncology to Present at the Credit Suisse Annual Healthcare Conference Download PDF format download (opens in new window)
October 31, 2013
Clovis Oncology Announces Third Quarter 2013 Operating Results Download PDF format download (opens in new window)
October 30, 2013
Clovis Oncology Announces First Patient Enrolled in ARIEL2 Study of Rucaparib in Ovarian Cancer Download PDF format download (opens in new window)
October 27, 2013
Clovis Oncology’s CO-1686 Continues to Demonstrate Promising Clinical Activity and Safety in Updated Phase I Study Results Download PDF format download (opens in new window)
October 23, 2013
Clovis Oncology to Announce Third Quarter 2013 Financial Results and Host Webcast Conference Call on October 31 Download PDF format download (opens in new window)
October 21, 2013
Clovis Oncology Announces Lung Cancer Diagnostic Collaboration with QIAGEN Download PDF format download (opens in new window)
September 29, 2013
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule Download PDF format download (opens in new window)
September 4, 2013
Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference Download PDF format download (opens in new window)
August 28, 2013
Clovis Oncology Announces First Patient Treated with Hydrobromide Salt Tablet Formulation of CO-1686 in its Ongoing Phase I/II Clinical Study Download PDF format download (opens in new window)
August 1, 2013
Clovis Oncology Announces Second Quarter 2013 Operating Results Download PDF format download (opens in new window)
July 24, 2013
Clovis Oncology to Announce Second Quarter 2013 Financial Results and Host Webcast Conference Call on August 1 Download PDF format download (opens in new window)
June 13, 2013
Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock Download PDF format download (opens in new window)
June 13, 2013
Clovis Oncology Welcomes Two New Directors to its Board Download PDF format download (opens in new window)
June 11, 2013
Clovis Oncology Announces Upsizing and Pricing of Public Offering of Common Stock Download PDF format download (opens in new window)
June 10, 2013
Clovis Oncology Announces Proposed Offering of Common Stock Download PDF format download (opens in new window)
June 3, 2013
Clovis Oncology’s Rucaparib Demonstrates Encouraging Results from Ongoing Phase I/II Monotherapy Study in Patients with Solid Tumors Download PDF format download (opens in new window)
June 3, 2013
Clovis Oncology’s CO-1686 Demonstrates Encouraging Results from Ongoing Phase I/II Study in EGFR-mutant Non-Small Cell Lung Cancer Download PDF format download (opens in new window)
May 16, 2013
Clovis Oncology Announces Clinical Data to be Presented at ASCO Annual Meeting 2013 Download PDF format download (opens in new window)
May 8, 2013
Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas Download PDF format download (opens in new window)
May 7, 2013
Clovis Oncology Announces First Quarter 2013 Operating Results Download PDF format download (opens in new window)
April 23, 2013
Clovis Oncology to Announce First Quarter 2013 Financial Results and Host Webcast Conference Call on May 7 Download PDF format download (opens in new window)
February 28, 2013
Clovis Oncology Announces 2012 Operating Results and 2013 Objectives Download PDF format download (opens in new window)
February 25, 2013
Clovis Oncology to Present at the Cowen Health Care Conference in Boston Download PDF format download (opens in new window)
February 14, 2013
Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28 Download PDF format download (opens in new window)
January 7, 2013
Clovis Oncology Announces 2013 Objectives and Financial Guidance Download PDF format download (opens in new window)
January 2, 2013
Clovis Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference Download PDF format download (opens in new window)